Suzhou Tianhong Shengjie Medical Devices Co., a leading Chinese peripheral vascular intervention company, has completed a tens-of-millions RMB equity financing round. The round was solely invested by Chuangjing Capital, a healthcare-focused investment firm, with Win-Cross Capital serving as the exclusive financial advisor. Tianhong Shengjie holds China's first registered iliac vein stent and operates a full-product-line commercialized in periphe…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.